Jubilant Pharmova Ltd.
BSE: 530019 | Sector: Health care |
NSE: JUBLPHARMA | ISIN Code: INE700A01033 |
BSE 15:42 | 27 Jan | 341.45 |
-4.90 (-1.41%) |
OPEN
347.15 |
HIGH
349.50 |
LOW
329.40 |
NSE 15:31 | 27 Jan | 337.65 |
-9.00 (-2.60%) |
OPEN
345.00 |
HIGH
350.05 |
LOW
331.05 |
OPEN | 347.15 |
PREVIOUS CLOSE | 346.35 |
VOLUME | 12565 |
52-Week high | 555.00 |
52-Week low | 305.20 |
P/E | 59.28 |
Mkt Cap.(Rs cr) | 5,439 |
Buy Price | 338.10 |
Buy Qty | 10.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Jubilant Pharmova Ltd. (JUBLPHARMA) - Financial Overview
Particulars (![]() |
2022 | 2021 | 2020 |
Net Sales | 87.75 | 2709.50 | 3139.90 |
Operating Profit | 119.09 | 474.94 | 542.44 |
Other Income | 125.87 | 47.88 | 173.23 |
Interest | 30.59 | 101.80 | 136.20 |
Depreciation | 6.25 | 99.97 | 107.40 |
Profit Before Tax | 82.25 | 273.17 | 298.84 |
Tax | 3.75 | 58.69 | -22.30 |
Profit After Tax | 78.50 | 214.48 | 321.14 |
Share Capital | 15.93 | 15.93 | 15.93 |
Reserves | 1265.89 | 1266.52 | 2591.37 |
Net Worth | 1281.82 | 1282.45 | 2607.30 |
Loans | 512.14 | 509.05 | 2079.44 |
Gross Block | 148.21 | 148.93 | 2288.40 |
Investments | 1645.75 | 1645.98 | 1764.03 |
Cash | 22.51 | 40.33 | 257.73 |
Debtors | 21.23 | 0.00 | 425.45 |
Net Working Capital | 24.61 | 18.11 | 998.89 |
Operating Profit Margin (%) | 135.72 | 17.53 | 17.28 |
Net Profit Margin (%) | 89.46 | 7.92 | 10.23 |
Earning Per Share (Rs) | 4.93 | 13.46 | 20.16 |
Dividend (%) | 500.00 | 500.00 | 500.00 |
Dividend Payout | 79.64 | 0.00 | 151.32 |
Quick Links for Jubilant Pharmova:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices